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Abstract  
Transient focal neurological episodes 
(TFNEs) are transient ischemic attack (TIA)-like 
episodes that may occur in patients with cerebral 
amyloid angiopathy (CAA). The duration of TFNEs 
is typically similar to TIAs with most symptoms 
resolving in minutes. Symptoms, similar to those of 
TIAs include sensory or visual disturbances, motor 
weakness and language impairment and there may 
be limb jerking or associated headache. TFNEs 
have a more gradual onset and tend to spread slowly 
to contiguous body parts like a migraine aura. 
TFNEs may occur repeatedly throughout the day 
and attacks may continue over several months. 
TFNEs are typically associated with focal cortical 
subarachnoid hemorrhage or with focal cortical 
superficial siderosis. They may also be seen in 
patients with CAA-related lobar hemorrhage, 
microhemorrhage or leukoencephalopathy. 
Migraine prophylactic agents such as verapamil and 
topiramate may be useful in stopping frequent 
recurrent TFNEs. TFNEs are an under-recognized 
cause of apparent TIAs. It is important to keep 
TFNEs in the differential diagnosis when a patient 
presents with a presumed TIA as thrombolysis or 
anticoagulation is relatively contraindicated in CAA. 
Gradient echo MRI should be performed to exclude 
microhemorrhages when TFNEs are suspected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinicians most frequently associate cerebral 
amyloid angiopathy (CAA) with intracerebral 
hemorrhage or with a clinical picture of vascular 
cognitive impairment.1 There have however, been 
increasing clinical reports documenting that CAA 
may cause a variety of acute clinical neurological 
manifestations.2 Although these phenomena are 
superficially similar to TIAs and may be mistaken 
for them, they have clinical time profiles and 
progressions that can distinguish them from TIAs 
clinically. They appear to be caused by different 
manifestations of the complications of CAA and are 
now known as transient focal neurological episodes 
(TFNE).2-3  
CAA frequency increases with age with 
approximately 50 % of individuals over the age of 
75 being affected. The exact cause of CAA remains 
uncertain however increased production and/or 
decreased breakdown of amyloid proteins may have 
a role. CAA predominantly affects occipital regions 
of the brain followed by frontal and temporal areas. 
Cerebellar vessels are less commonly affected.3 The 
Boston criteria is the current standard criteria for 
diagnosis of CAA. In this review, we attempt to 
classify and describe the different causes of TFNE’s 
in CAA. 
 
Clinical Manifestations of TFNEs 
TFNE’s include all neurological phenomena 
that may be otherwise attributed to TIA’s as well as 
other atypical symptoms that are specific to 
TNFE’s.1 The duration of TFNE’s is quite similar 
to TIA’s with most symptoms resolving before 24 
hours. Some cases of TFNE’s have been reported to 
occur for longer but resolve eventually unlike major 
cerebrovascular accidents. Symptoms similar to 
those of TIA’s include sensory disturbances, motor 
weakness, visual disturbances and language 
impairment. Atypical symptoms include associated 
headache and focal jerking 2-3  
TFNE’s vary from TIA’s in that symptoms 
often spread to contiguous body parts much like 
migraine attacks.3 TFNE’s also have a more gradual 
TIA-like presentations of cerebral amyloid 
angiopathy 
 
 
Bernard Galea, Anna Pullicino, Patrick Pullicino 
Bernard Galea, M.D.  
University of Malta 
Msida, Malta  
 
Anna Pullicino 
Malta Medical School 
Msida, Malta  
 
Patrick Pullicino* M.D., Ph.D.  
Kent and Canterbury Hospital,  
Canterbury, UK 
P.Pullicino@kent.ac.uk 
 
*Corresponding Author  
29
Case rEditorial Editorial OrgOdRe 
 
 
 
Review Article   
 
Malta Medical Journal     Volume 30 Issue 02 2018                                                                                                                                                                             
 
 
onset unlike TIA’s which often have an abrupt 
onset. TFNE’s are also more likely to occur 
multiple times during the day unlike TIA’s which 
usually happen in single episodes or if multiple 
usually days apart.2,3 TFNEs may occur repeatedly 
over several months and be a very intrusive 
symptom for the patient.25 The typical presentation 
of a TFNE is of parasthesias involving one or more 
limbs that spread gradually to involve contiguous 
areas of that same limb. A TFNE may resolve 
partially or completely before recurring again later 
on during the day. 
 
TFNEs with Cerebral Microhemorrhage. 
Cerebral microhemorrhage that occur as part 
of CAA (Figure 1) may be a cause of TFNE’s.10, 18 
Microhemorrhages are visualised in 47.4% of 
patients with CAA confirmed on pathology.  
Risk for eventual conversion to lobar 
intracerebral hemorrhage (ICH) is significantly 
increased at the sites of microhemorrhage. The risk 
for microhemorrhage is higher in local areas of 
confirmed CAA and is directly proportional to the 
density of amyloid deposition in blood vessels. 
Increasing numbers of microhemorrhages in a 
localised area may be suggestive of a future ICH so 
this can be used as a predictive tool. While most 
cerebral microhemorrhages are usually 
asymptomatic, microhemorrhages were associated 
with TFNE’s in several case studies.6,11-14  
 
 
 
 
Figure 1:  Multiple bilateral microhemorrhages in a lobar distribution 12 
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TFNEs with Focal Cortical Subarachnoid 
Hemorrhage and Cortical Superficial Siderosis. 
The most frequent cause for TFNE’s in CAA 
is focal cortical subarachnoid hemorrhage with 
resulting Cortical Superficial Siderosis (CSS).16 
(Figure 2) In CAA, subarachnoid hemorrhages 
typically occur in a focal convexity pattern along 
brain areas with a high CAA density. 4 Eventual 
conversion to superficial siderosis occurs after 
blood products are cleared from CSF spaces. 5 CSS 
can be defined as hemosiderin deposits in the 
subpial space that occur after repeated bleeding into 
the subarachnoid space. CAA-mediated 
subarachnoid hemorrhage may present with TIA-
like symptoms as well as headache and ictal 
symptoms.8-9 
CSS occurs in up to 61% of pathologically 
confirmed cases of CAA and increases the risk for 
lobar ICH significantly.16,17 Even though CSS 
occurs mainly in areas where previous 
microhemorrhages were present, it generally occurs 
in patients with CAA with a lower 
microhemorrhage overall burden.4 CSS associated 
with CAA may also be found in Alzheimer’s 
Dementia and/or mild cognitive impairment 
patients who have a higher prevelance of CSS when 
compared to the general population. Current Boston 
Criteria for diagnosis of CAA does not include 
subarachnoid hemorrhage.18-19 
15 % of patients with CAA experienced 
TFNE’s at some point in one multicenter cohort 
study. Patients with CAA and evidence of CSS 
were more likely to experience TFNE’s when 
compared to CAA patients with no evidence of 
subarachnoid hemorrhage or CSS (50% vs 19%). 50 
% of TFNE patients experienced subsequent ICH 
over a median period of 14 months.1,2 
 
 
Figure 2:  a) Right rolandic sulcus subarachnoid hemorrhage on T2-Gradient Echo MRI b) Conversion of 
blood to CSS 8 months later8 c) Cortical Superficial Siderosis (CSS) left parietal lobe on T2- Gradient echo in 
a patient presenting with a transient aphasia and right motor deficit. 1 Also shows bilateral white matter T2 
hyperintensity due to leukoencephalopathy. d) CSS in multiple gyri (arrows) in a patient with recurrent 
spreading parasthesia in right upper limb.15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(c) (d) 
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TFNEs Associated with Intracerebral 
Hemorrhage. 
ICH is known complication of CAA.(Figure 
3) The Helsinki ICH study found that 20% of ICHs 
occurred in patients with CAA in cortical areas that 
had higher amyloid angiopathy volume.22  
ICH in CAA patients typically follows a lobar 
distribution rather than affecting deep structures of 
the brain as amyloid is deposited preferentially in 
meningeal and cortical blood vessels. Even though 
a significant proportion of ICH symptoms never 
resolve, CAA-mediated ICH has been implicated as 
a cause for TFNE’s with complete resolution of 
symptoms in these instances. 21-24 
 
 
TFNEs with Cerebral amyloid angiopathy-
related inflammation 
Apart from hemorrhagic events, CAA is also 
associated with transient focal white matter 
vasogenic edema.(Figure 4) These white matter 
changes exert a variable degree of mass effect but 
are not enhanced by contrast. These lesions tend to 
present with worsening cognition, headache and 
stroke like symptoms. They may give symptoms 
spreading gradually to contiguous body parts. These 
lesions usually present with subacute cognitive 
changes, seizures and headache. Symptoms are 
usually transient in nature but they tend to last 
longer than TFNE’s. These lesions may respond to 
steroids, or immunotherapy.  
 
 
Figure 3:  Intracerebral hemorrhage in a patient with CAA confirmed using Boston criteria. (two separate 
axial planes from same image) 1 8 
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Figure 4: Cerebral amyloid angiopathy-related inflammation involving left temporal and occipital lobes.26 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TFNEs with leukoencephalopathy 
Leukoencephalopathy (Figure 2c) volume is 
directly related to CAA volume and tends to occur 
predominately in the frontal and parietal lobes first 
(70 % of all patients) followed by temporal and 
occipital regions (15% and 10 %).25,26 
Leukoencephalopathy is associated with an 
increased risk of subsequent ICH in the areas most 
heavily affected. This finding suggests that ICH in 
CAA may occur as a result of two separate but 
related complications of CAA (dysregulated blood 
flow and increased susceptibly of hemorrhage from 
blood vessels with amyloid deposits).25,26 
Several TIA-like episodes in known CAA patients 
had no evidence of overt pathology on imaging 
(subarachnoid hemorrhage, CSS or ICH) but did 
have a variable degree of leukoencephalopathy. 
This finding suggests that focal ischemia related to 
these white matter changes are another cause for 
TFNE’s in CAA.7,25,26 
 
Conclusion 
CAA mediated TFNE’s are an under-
recognized cause of acute neurological symptoms. 
It is important to keep TFNEs as part of the 
differential diagnosis when a patient presents with a 
presumed TIA. The features distinguishing TIA’s 
from TFNE’s should always be sought using 
appropriate history taking, clinical examination and 
specific imaging. 
Thrombolysis using IV-tPA or oral 
anticoagulation has been reported in patients with 
CAA-related TFNE’s due to the misdiagnosis with 
TIA. 5, 20 Patients with TFNE’s treated with 
thrombolytic therapy or anticoagulation were more 
likely to develop ICH when compared to those who 
did not receive therapy.6 This finding questions the 
safety of the usage of anticoagulation / thrombolytic 
therapy in patients with TIA-like symptoms without 
prior exclusion of CAA-mediated subarachnoid 
hemorrhage using specific blood sensitive imaging 
such as T2-gradient echo MRI.5,6,20 
Recent case reports suggest that agents used in 
migraine prophylaxis (verapamil or topirimate) may 
have a role in treating frequent recurrent  TFNE’s 
that persist over weeks or months and do not 
resolve spotaneously. In TFNE’s caused by cerebral 
amyloid angiopathy-related inflammation, the 
lesions may respond to steroids.  
 
 
 
 
33
Case rEditorial Editorial OrgOdRe 
 
 
 
Review Article   
 
Malta Medical Journal     Volume 30 Issue 02 2018                                                                                                                                                                             
 
 
References 
1. Maia LF, Mackenzie IR, Feldman HH.: Clinical 
 phenotypes of cerebral amyloid angiopathy, J Neurol 
 Sci 2007;257:23–30. 
2. Charidimou A, Peeters A, Fox Z, Gregoire SM, 
 Vandermeeren Y, Laloux P, et al. Spectrum of transient 
 focal neurological episodes in cerebral amyloid 
 angiopathy. Stroke 2012;43:2324-2330. 
3. Illsley A, and Ramadan H, Cerebral amyloid 
 angiopathy- a transient ischaemic attack mimic. 
 2014;14:255–9. 
4. Apoil M, Cogez J, Dubuc L, Bataille M, de la Sayette 
 V, Touzé E, et al. Focal cortical subarachnoid 
 hemorrhage revealed by recurrent paresthesias- A 
 clinico-radiological syndrome strongly associated with 
 cerebral amyloid angiopathy, Cerebrovasc Dis 
 2013;36:139–144. 
5. Chang GY. Cerebral amyloid angiopathy presenting as 
 a sequential cheiro-oral syndrome, Neurol Asia 
 2014;19:317 – 318. 
6. Charidimou A, Baron JC, and Werring DJ. Transient 
 focal neurological episodes, cerebral amyloid 
 angiopathy, and intracerebral hemorrhage risk- looking 
 beyond TIAs, Int J Stroke 2013;8:105–108. 
7. Cano LM, Martínez-Yélamos S, Majós C, Albertí MA, 
 Boluda S, Velasco R, et al. Reversible acute 
 leukoencephalopathy as a form of presentation in 
 cerebral amyloid angiopathy, J Neurol Sci 2010;288: 
 190–193. 
8. Raposo N, Viguier A, Cuvinciuc V, Calviere L, 
 Cognard C, Bonneville F, et al. Cortical subarachnoid 
 hemorrhage in the elderly- a recurrent event probably 
 related to cerebral amyloid angiopathy, Eur J Neurol 
 2011;18:597–603. 
9. Brunot S, Osseby GV, Rouaud O, Kazemi A, Ricolfi F, 
 Couvreur G, et al. Transient ischaemic attack mimics 
 revealing focal subarachnoid hemmorhage, 
 Cerebrovasc Dis 2010;30:597–601. 
10. Brundel M, Heringa SM, de Bresser J, Koek HL, 
 Zwanenburg JJ, Jaap Kappelle L, et al. High prevalence 
 of cerebral microbleeds at 7Tesla MRI in patients with 
 early Alzheimer’s disease. J Alzheimers Dis 
 2012;31:259-263. 
11. Dierksen GA, Skehan ME, Khan MA, Jeng J, 
 Nandigam RN, Becker JA, et al. Spatial relation 
 between microbleeds and amyloid deposits in amyloid 
 angiopathy. Ann Neurol 2010;68:545-548. 
12. Yates PA, Sirisriro R, Villemagne VL, Farquharson S, 
 Masters CL, Rowe CC, et al. Cerebral 
 microhemorrhage and brain β-amyloid in aging and 
 Alzheimer disease. Neurology 2011;77:48-54 
13. Van Etten ES, Auriel E, Haley KE, Ayres AM, 
 Vashkevich A, Schwab KM, et al. Incidence of 
 symptomatic hemorrhage in patients with lobar 
 microbleeds. Stroke 2014;45:2280-2285.  
14. Gurol ME, Dierksen G, Betensky R, Gidicsin C, Halpin 
 A, Becker A, et al. Predicting sites of new hemorrhage 
 with amyloid imaging in cerebral amyloid angiopathy. 
 Neurology 2012; 79:320-326. 
 
 
15. Feldman HH, Maia LF, Mackenzie IR, Forster BB, 
 Martzke J, Woolfenden A. Superficial siderosis: a 
 potential diagnostic marker of cerebral amyloid 
 angiopathy in Alzheimer disease. Stroke 2008;39:2894-
 2897.  
16. Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, 
 Dichgans M, et al. Prevalence of superficial siderosis in 
 patients with cerebral amyloid angiopathy. Neurology 
 2010;74:1346-1350.  
17. Charidimou A, Peeters AP, Jäger R, Fox Z, 
 Vandermeeren Y, Laloux P, et al. Cortical superficial 
 siderosis and intracerebral hemorrhage risk in cerebral 
 amyloid angiopathy. Neurology 2013;81:1666-1673.  
18. Shoamanesh A, Martinez-Ramirez S, Oliveira-Filho J, 
 Reijmer Y, Falcone GJ, Ayres A, et al. Interrelationship 
 of superficial siderosis and microbleeds in cerebral 
 amyloid angiopathy. Neurology 2014;83:1838-1843. 
19. Wollenweber FA, Buerger K, Mueller C, Ertl-Wagner 
 B, Malik R, Dichgans M, et al. Prevalence of cortical 
 superficial siderosis in patients with cognitive 
 impairment. J Neurol 2014;261: 277-282. 
20. Linn J, Wollenweber FA, Lummel N, Bochmann K, 
 Pfefferkorn T, Gschwendtner A, et al. Superficial 
 siderosis is a warning sign for future intracranial 
 hemorrhage. J Neurol 2013; 260:176-181. 
21. Meretoja A, Strbian D, Putaala J, Curtze S, Haapaniemi 
 E, Mustanoja S, et al. SMASH-U: a proposal for 
 etiologic classification of intracerebral hemorrhage. 
 Stroke 2012;43:2592-2597. 
22. Béjot Y, Cordonnier C, Durier J, Aboa-Eboulé C, 
 Rouaud O, Giroud M. Intracerebral hemorrhage 
 profiles are changing: results from the Dijon 
 population-based study, Brain 2013;136: 658-664. 
23. Samarasekera N, Smith C, Al-Shahi Salman R: The 
 association between cerebral amyloid angiopathy and 
 intracerebral hemorrhage: systematic review and meta-
 analysis. J Neurol Neurosurg Psychiatry 2012;83:275-
 81. 
24. Paterson RW,  Uchino K, Emsley H, Pullicino P. 
 Recurrent stereotyped episodes in cerebral amyloid 
 angiopathy: Response to migraine prophylaxis. 
 Cerebrovasc Dis Extra 2013;3:81-4. 
25.  Savoiardo M, Erbetta A, Di Francesco JC, Brioschi M, 
 Silani V, Falini A, et al.  Amyloid angiopathy-related 
 inflammation: an emerging disease, Neuroradiol J. 
 2011;24:253-257. 
26.  Maxime St-Amant,  A.Frank Gaillard et al. 
 Radiopaedia at https://radiopaedia.org/articles/cerebral-
 amyloid-angiopathy-related-inflammation-2 
 
 
34
